Moleculin Biotech
| Region | Nordamerika |
| ISIN | US60855D1019 |
| Sektor | Biotechnologie |
| Website | http://www.moleculin.com/ |
Moleculin Biotech is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center.
| Titel | Datum |
|---|---|
| ABS Approves MISC and China Offshore's Ammonia FPSO Design | vor 11 Tagen |
| MISC Berhad and China Offshore secure ABS approval in principle for ammonia FPSO concept | vor 11 Tagen |
| MISC and China Offshore's ammonia FPSO design wins ABS' blessing | vor 11 Tagen |
| MISC, China Offshore Secure US Approval For Pioneering Ammonia FPSO Design | vor 11 Tagen |
| Stock Today: MISC Gains 0.41% Amid Offshore Contract Win | vor 17 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Minori Solutions (1 Artikel) | |
| Microsoft (1 Artikel) | |
| Moovly Media (1 Artikel) | |
| MorphoSys (1 Artikel) | |
| Alle anzeigen | |